Literature DB >> 23182087

Synthesis and anti-angiogenic activity of benzothiazole, benzimidazole containing phthalimide derivatives.

Shunmugam Nagarajan1, Syamantak Majumder, Upendra Sharma, Saranya Rajendran, Neeraj Kumar, Suvro Chatterjee, Bikram Singh.   

Abstract

Benzothiazole and benzimidazole containing phthalimide derivatives (NK037, NK041, NK042, NK0139A and NK0148) have been synthesized and their anti-angiogenic activity was evaluated using ex vivo egg yolk angiogenesis model. A comparative study with pure thalidomide (NKTA) has also been performed to describe the efficacy of these derivatives in blocking angiogenesis. NK037, NK041 and NK042 were equally potent in blocking egg yolk angiogenesis and the anti-angiogenesis effect was higher than NKTA suggesting the efficacy of these three derivatives in blocking angiogenesis when compare to control. Other two derivatives NK0139A and NK0148 showed effect less than NKTA and stronger than control in ex vivo angiogenesis.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182087     DOI: 10.1016/j.bmcl.2012.10.106

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Design and Synthesis of 4-flurophthalimides as potential anticonvulsant agents.

Authors:  Maryam Iman; Sina Fakhari; Mohammad Jahanpanah; Nima Naderi; Asghar Davood
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

2.  Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos.

Authors:  Annalisa Mercurio; Lucy Sharples; Filomena Corbo; Carlo Franchini; Angelo Vacca; Alessia Catalano; Alessia Carocci; Roger D Kamm; Andrea Pavesi; Giulia Adriani
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.